Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
According to a story from globenewswire.com, the gene and cell therapy company Abeona Therapeutics Inc. recently announced that has received a letter from the US Food and Drug Administration (FDA)…